Some evidence from large multinational cohorts supports an increased risk for asthma and allergic rhinitis, after SARS-CoV-2 ...

The India HIV Estimates 2024 report highlights major improvements in treatment access, early diagnosis and state-level ...

It's an evolutionary battle, an endless competition for survival, that has spanned millions of years. Within this epic tale ...

Sharing India's latest progress indicators, Nadda underlined that the country has achieved a 35 per cent reduction in new HIV ...

People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe ...

The verdict? The vaccine is the safest bet by far. The very rare, short-term risk of heart inflammation caused by the vaccine ...

For the first time in the 2025-2026 season, Japanese encephalitis has been detected in Victoria, with the virus found in a ...

About 5 million people worldwide live with the autoimmune condition lupus. This condition can cause a range of symptoms, ...

As we get deeper into flu season, a new type of the influenza virus has been identified, the Centers for Disease Control and ...

Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered compelling ...

A new study led by University of Toronto researchers has shown that immune cells in the gut follow an atypical pathway to produce antibodies that provide long-term protection against viruses.

A new study led by University of Toronto researchers has shown that immune cells in the gut follow an atypical pathway to produce antibodies that provide long-term protection against viruses.